COCP Stock Research Snapshot: Pipeline, Catalysts, and Cash Runway

Cocrystal Pharma Inc | Needs refresh | Last updated: 2026-06-01T17:55:29Z

TickerCOCP

Market Cap15.1M

Cash RunwayRunway 6-12 months

Next Catalyst2026-10-01

Public Research Snapshot

Cocrystal Pharma Inc is a publicly tracked healthcare company. This research snapshot summarizes public information on pipeline assets, clinical trials, upcoming catalysts, SEC filings, and cash runway estimates for CC-42344 in Influenza A (Phase 2) using Vaccine.

Pipeline

Asset	Indication	Modality	Stage	Public Note
COVID-19	n/a	n/a	n/a	Public pipeline row
CDI-988	Norovirus	n/a	n/a	Public pipeline row
CC-42344	Influenza A	Vaccine	Phase 2	Public pipeline row
CDI-31244	Hepatitis C	n/a	Phase 2	Public pipeline row

Catalyst Preview

Company	Ticker	Catalyst	Timing	Asset	Confidence
		Clinical Trial Completion	2026-10-01	CDI-988	Low

Cash Runway Preview

Estimated cash runway: Runway 6-12 months.

This is an automated estimate and may differ from company guidance.

Recent SEC Filings

No public filing rows are loaded yet.

Clinical Trial Activity

NCT ID	Phase	Status	Enrollment	Primary Completion
NCT02760758	Phase 1	COMPLETED	76	2017-03
NCT03501550	Phase 2	COMPLETED	12	2019-01-08
NCT05202379	Phase 1	COMPLETED	80	2023-03-29
NCT06160531	Phase 2	COMPLETED	78	2024-05-03
NCT07198139	Phase 1 \| Phase 2	RECRUITING	40	2026-10-01

Scientific Context

literature_publication | Best practices for screening, testing, diagnosing, and treating patients with hepatitis D (delta) virus based on global expert review and recent guidelines.
literature_publication | The seventh blind test of crystal structure prediction: structure generation methods.
literature_publication | Optimization of a Novel DEL Hit That Binds in the Cbl-b SH2 Domain and Blocks Substrate Binding.
literature_publication | Experience and impact of stigma in people with chronic hepatitis B: a qualitative study in Asia, Europe, and the United States.
literature_publication | A Commentary on Co-Processed API as a Promising Approach to Improve Sustainability for the Pharmaceutical Industry.

Want the full COCP research brief?

Subscribe for source-linked catalyst analysis, cash runway monitoring, and clinical trial change alerts.

Get the weekly biotech catalyst watchlist

This page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. Data may be incomplete or delayed. Cash runway and catalyst timing estimates are derived from public sources and may differ from company guidance.